S Sean Tu (Sean S Tu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Rheumatoid Arthritis

Preterm Infants

Top Venues

Nature biotechnology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

S Sean Tu, Dinis Cheian, Sarah Gabriele, Benjamin N Rome, Aaron S Kesselheim
The cost of drug patent expiration date errors. Nature biotechnology 42 (7) (2024)
Victor L Van de Wiele, Aaron S Kesselheim, S Sean Tu
Biologic patent challenges under the America Invents Act. Nature biotechnology 42 (3) (2024)
Victor L Van de Wiele, Aaron S Kesselheim, S Sean Tu
Biologic patent challenges under the America Invents Act. Nature biotechnology 42 (3) (2024)
S Sean Tu, Dinis Cheian, Sarah Gabriele, Benjamin N Rome, Aaron S Kesselheim
The cost of drug patent expiration date errors. Nature biotechnology 42 (7) (2024)
Anders Olsen, Reed F Beall, Ryan P Knox, S Sean Tu, Aaron S Kesselheim, William B Feldman
Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019. PLoS medicine 20 (11) (2023)
Victor L Van de Wiele, Aaron S Kesselheim, Sarosh Nagar, S Sean Tu
The prevalence of drug patent term extensions in the United States, 2000-2018. Nature biotechnology 41 (7) (2023)
S Sean Tu, Aaron S Kesselheim
Preserving Timely Generic Drug Competition with Legislation on "Skinny Labeling". Clinical pharmacology and therapeutics (2023)